- Home
- NVT vs BNTX Comparison
NVT vs BNTX Comparison
Compare NVT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVT | BNTX |
|---|---|---|
| Founded | 1903 | 2008 |
| Country | United Kingdom | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 24.2B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NVT | BNTX |
|---|---|---|
| Price | $162.86 | $87.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 13 |
| Target Price | $131.36 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 1.7M | 753.0K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | ★ 118.78 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $3,893,100,000.00 | N/A |
| Revenue This Year | $19.44 | N/A |
| Revenue Next Year | $12.41 | $3.37 |
| P/E Ratio | $199.84 | ★ N/A |
| Revenue Growth | ★ 29.51 | N/A |
| 52 Week Low | $67.23 | $79.81 |
| 52 Week High | $178.00 | $124.00 |
Technical Indicators
Market Signals| Indicator | NVT | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 39.18 |
| Support Level | $92.46 | $86.16 |
| Resistance Level | $175.00 | $113.32 |
| Average True Range (ATR) | 7.17 | 2.57 |
| MACD | -1.18 | -0.18 |
| Stochastic Oscillator | 39.13 | 5.45 |
Price Performance
Historical ComparisonAbout NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.